Nipro Corporation (TYO:8086)

Market Cap	236.81B
Revenue (ttm)	649.95B
Net Income (ttm)	10.89B
Shares Out	163.10M
EPS (ttm)	59.16
PE Ratio	24.54
Forward PE	17.24
Dividend	28.00 (1.92%)
Ex-Dividend Date	Mar 30, 2026

Volume	435,200
Average Volume	437,900
Open	1,450.00
Previous Close	1,456.50
Day's Range	1,441.00 - 1,456.00
52-Week Range	1,230.50 - 1,578.00
Beta	-0.08
RSI	42.57
Earnings Date	Feb 9, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company’...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1947
• Employees: 39,168
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 8086

Financial Performance

In 2024, Nipro's revenue was 644.59 billion, an increase of 9.85% compared to the previous year's 586.79 billion. Earnings were 5.11 billion, a decrease of -53.97%.